The reason was simple. They didn't have the funds to do the clinical trials necessary to get FDA approval for something like vitiligo. They did have the funding to do the trials for burns, thanks to their contract with BARDA. I've said it before, without American taxpayers who fund BARDA there probably wouldn't be an Avita at this point. It's likely in my opinion that Perry had a large role in procuring that contract.
Market share, page-2
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
0.010(0.41%) |
Mkt cap ! $160.4M | |||
| Open | High | Low | Value | Volume |
| $2.42 | $2.45 | $2.41 | $562.3K | 231.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 82002 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 16 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |